Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Collins, MA

Brian Collins, Allston, MA US

Patent application numberDescriptionPublished
20080270398Product affinity engine and method - The present invention relates to a computerized engine and method for using the same to determine and effect product sales to customers based on customer-driven affinities relating to the products. In some embodiments, the computerized engine includes hardware and software and uses customer or transaction data or product characteristics to calculate an output relating to the affinity. In some embodiments, the computerized engine provides an output indicative of the affinity. In some embodiments, the computerized engine is coupled to a database containing the customer or transaction data or product characteristics. The system and method can also determine a reduced affinity depending on a period of time elapsed between a pair of events being related, or as a function of the age of collected affinity data.10-30-2008

Brian Edward Collins, Arlington, MA US

Patent application numberDescriptionPublished
20100129843CHARACTERIZATION OF N-GLYCANS USING EXOGLYCOSIDASES - The present disclosure provides methods for analyzing structure and/or composition of N-glycans. Such methods often involve digestion of N-glycans with multiple exoglycosidases. In some embodiments, N-glycans are digested with multiple exoglycosidases simultaneously. In some embodiments, N-glycans are digested with multiple exoglycosidases sequentially. In some embodiments, methods in accordance with the present disclosure involve comparison of cleavage products of N-glycans that have been digested with multiple exoglycosidases simultaneously to N-glycans that have been digested with multiple exoglycosidases sequentially.05-27-2010
20100151499PROTEOLYTIC RELEASE OF GLYCANS - The present disclosure provides strategies for analyzing protein-linked glycans, and particularly for analyzing glycans on cell surface glycoproteins.06-17-2010
20100196940METHODS RELATED TO CELL SURFACE GLYCOSYLATION - The present disclosure provides methods for assessing the glycosylation of a target glycoprotein produced by a cell through analysis of cell-surface glycans on the cell. The present disclosure therefore teaches that glycosylation of cell surface proteins can serve as a proxy for glycosylation of other proteins.08-05-2010
20110213137ISOTOPICALLY-LABELED GLYCANS - The present disclosure provides methods of making isotopically-labeled glycans or a mixture of glycans (e.g., a glycan preparation) via reductive amination. Such methods are useful, for example, in the determination of the relative amounts of a glycan species present in two or more glycoprotein preparations using mass spectroscopy. In one aspect, the present disclosure provides a method of making an isotopically-labeled glycan by a glycan with an amine and an isotopically-labeled reducing agent to provide an isotopically-labeled aminated glycan. In certain embodiments, the amine is an isotopically-labeled amine.09-01-2011

Brian Edward Collins, Somerville, MA US

Patent application numberDescriptionPublished
20100113294DEFINED GLYCOPROTEIN PRODUCTS AND RELATED METHODS - The invention provides methods, databases and systems for making glycoprotein products having defined properties.05-06-2010

Christopher H. Collins, Melrose, MA US

Patent application numberDescriptionPublished
20110256378CROSS LINKING MEMBRANE SURFACES - The present invention relates, in part, to high energy processes for manufacturing cross-linked polyolefins. The polyolefins described herein are capable of undergoing further processing without compromising their physical properties and dynamic performance.10-20-2011

David J. Collins, Duxbury, MA US

Patent application numberDescriptionPublished
20100077116System for processing code data - A software application that is installed in a commercially available processor, which application; identifies a keystroke data stream as derived from a code pattern, stores the pattern in system memory, validates the data stream, extracts user identified fields, adds prefixes and suffixes to the fields, and transmits identified fields to the processor operating system as a keystroke emulating data stream. The DOD UID code, and other similar codes, specifies a lead character or characters as a code identifier. When the application of this invention detects this code identifying lead character it directs the processor operating system to store the character and subsequent characters in the system memory rather than process them as entries from a keyboard. The application sets a timer as each character is received. As long as the timer does not time out, each successive character in the stream is treated as part of the code data until a code specified end of data character is detected.03-25-2010

Gregory Collins, East Sandwich, MA US

Patent application numberDescriptionPublished
20090324558Transdiscal administration of cycline compounds - The present invention relates to administering a doxycycline compound into a diseased intervertebral disc.12-31-2009

Patent applications by Gregory Collins, East Sandwich, MA US

James Collins, Newton, MA US

Patent application numberDescriptionPublished
20090264342COMPOSITIONS AND METHODS FOR ANTIBIOTIC POTENTIATION AND DRUG DISCOVERY - The present invention provides methods for identifying target genes whose partial or complete functional inactivation potentiates the activity of an antibiotic agent, e.g., a quinolone antibiotic. The invention further provides methods for identifying agents that modulate expression of target genes or that modulate activity of expression products of target genes. Agents identified according to various methods of the invention potentiate the activity of antibiotics such as quinolones, aminoglycosides, peptide antibiotics and β-lactams. Also provided are agents that suppress and/or retard resistance to antibiotics. The inventive methods provide potentiating agents and compositions comprising potentiating agents and antibiotics. Such agents and compositions can be used for inhibiting growth or survival of a microbial cell or of treating a subject suffering from or susceptible to a microbial infection.10-22-2009
20100029597RECA INHIBITORS WITH ANTIBIOTIC ACTIVITY, COMPOSITIONS AND METHODS OF USE - The present invention is directed to the use of RecA inhibitors as antibiotic agents, and provides RecA inhibitors useful in treating infections. Also provided are various compositions and methods associated with RecA inhibition.02-04-2010

James J. Collins, Newton Center, MA US

Patent application numberDescriptionPublished
20090155215ENGINEERED ENZYMATICALLY ACTIVE BACTERIOPHAGE AND METHODS FOR DISPERSING BIOFILMS - The present invention is directed to engineered enzymatically active bacteriophages that are both capable of killing the bacteria by lysis and dispersing the bacterial biofilm because they have been also engineered to express biofilm-degrading enzymes, particularly dispersin B (DspB), an enzyme that hydrolyzes β-1,6-N-acetyl-D-glucosamine, a crucial adhesion molecule needed for biofilm formation and integrity in 06-18-2009

James J. Collins, Newton, MA US

Patent application numberDescriptionPublished
20100175141TUNABLE GENETIC SWITCH FOR REGULATING GENE EXPRESSION - The present invention relates generally the field of genetics, in particular methods, compositions and systems for controlling the inducible expression of transgenes, while eliminating background expression of transgene expression. The present invention relates to methods of use of the compositions and systems as disclosed herein for controlling the inducible expression of transgenes while eliminating background expression of transgene expression, such as use in, for example, the in generation of transgenic animals, use in therapeutic application and use in assays. In some embodiments, the present invention relates to a system of controlled expression of RNAi molecules which target binding sites in the untranslated regions of transgene, thereby the expression of the transgene is modulated and leakiness is reduced. The compositions and methods of the present invention can be used to for therapy, prophylaxis, research and diagnostics in diseases and disorders which afflict mammalian species, generation of transgenic animals, in the study of biological processes as well as for enhance performance of agricultural crops.07-08-2010
20100322903ENGINEERED BACTERIOPHAGES AS ADJUVANTS FOR ANTIMICROBIAL AGENTS AND COMPOSITIONS AND METHODS OF USE THEREOF - The present invention relates to the treatment and prevention of bacteria and bacterial infections. In particular, the present invention relates to engineered bacteriophages used in combination with antimicrobial agents to potentiate the antimicrobial effect and bacterial killing by the antimicrobial agent. The present invention generally relates to methods and compositions comprising engineered bacteriophages and antimicrobial agents for the treatment of bacteria, and more particularly to bacteriophages comprising agents that inhibit antibiotic resistance genes and/or cell survival genes, and/or bacteriophages comprising repressors of SOS response genes or inhibitors of antimicrobial defense genes and/or expressing an agent which increases the sensitivity of bacteria to an antimicrobial agent in combination with at least one antimicrobial agent, and their use thereof.12-23-2010
20110097721IN VIVO GENE SENSORS - Described are methods and compositions for the detection of target genes. The inventors have developed a synthetic nucleic acid sensor-effector gene circuit. In cells without a target gene, the circuit suppresses e.g., effector production, but in the presence of the target gene the suppression is subject to competition, such that the synthetic sensor is de-repressed and permits expression of the effector gene. The methods and compositions described further permit the selective expression of an effector gene in those cells expressing the target gene. In this manner, cells expressing a target gene can be selectively targeted for treatment or elimination. In certain aspects, the methods and compositions described permit the selective expression of an agent such as a therapeutic gene product, in a specifically targeted population of cells in an organism.04-28-2011
20110119259NETWORK BIOLOGY APPROACH FOR IDENTIFYING TARGETS FOR COMBINATION THERAPIES - Described herein is a network biology approach useful for the identification of multiple therapeutic targets, which can be targeted simultaneously using an agent (or a plurality of agents) to modulate cellular phenotypes, or in combination with pharmaceutical compounds to improve drug sensitivity and/or reduce drug doses to maintain efficacy while minimizing side effects. The preferred approach disclosed herein relies on first identifying the mediators of a condition of interest, and second, selecting gene combinations that are in competing/parallel pathways as targets for combination therapy.05-19-2011
20120003630MODULAR NUCLEIC ACID-BASED CIRCUITS FOR COUNTERS, BINARY OPERATIONS, MEMORY, AND LOGIC - We have created novel engineered genetic counter designs and methods of use thereof that utilize DNA recombinases to provide modular systems, termed single invertase memory modules (SIMMs), for encoding memory in cells and cellular systems. Our designs are easily extended to compute to high numbers, by utilizing the >100 known recombinases to create subsequent modules. Flexibility in our engineered genetic counter designs is provided by daisy-chaining individual modular components, i.e., SIMMs together. These modular components of the engineered genetic counters can be combined in other network topologies to create circuits that perform, amongst other things, logic and memory. Our novel engineered genetic counter designs allow for the maintenance of memory and provide the ability to count between discrete states by expressing the recombinases between their cognate recognition sites.01-05-2012

Patent applications by James J. Collins, Newton, MA US

James Matthew Collins, Arlington, MA US

Patent application numberDescriptionPublished
20080319383Needle-Free Injection Device - A fluid injecting device (12-25-2008

John J. Collins, South Hamilton, MA US

Patent application numberDescriptionPublished
20120089612FLEXIBLE FULLY INTEGRATED REAL-TIME DOCUMENT INDEXING - A system for real-time document indexing is provided that includes a browser that is executing on a client system. The browser includes functionalities allowing it to communicate with a remote computer system. A query interface executes within the framework of the browser. The query interface receives one or more query searches from an end-user and sends the one or more query searches to be processed by the remote computer system. The remote computer system sends to the query interface the results of the one or more query searches via the browser. The query interface assigns the results of the one or more query searches to a folder where the folder includes a unique identifier. The query interface indexes the results of the one or more query searches to the unique identifier of the folder.04-12-2012
20120089676LIVE DATA FORM VIEWING AND UPDATING SYSTEM - A live data form system is provided that includes a client that executes a browser that receives one or more user requests to view or update a live data form being stored remotely. The live data form includes a plurality of data blocks having information that defines the live data form. The browser issues a first message with respect to viewing or updating the live data form. A server receives the first message and executes a first routine that analyzes the contents of the first message and formulates one or more query statements associated with a data block to be executed by one or more remote databases. When the one or more remote databases finish performing the one or more query statements, the server issues a second message to the browser that includes the results of the one or more query statements executed by the one or more remote databases via the client to either view or update the live data form.04-12-2012
20120089706MOBILE FILE UPLOADER - A mobile file uploading system is provided that includes a browser receiving a request to upload one or more selective files and issues a first message. A server receives the first message and determines whether the first message is requesting a download of a first software application, and if so, the server downloads to the user desktop the first software application where the browser executes the first software application. A file upload module is created when the browser completely executes the first software application. The file upload module manages uploading the one or more selective files from the user desktop to the server when a second message is sent by the browser. The file upload module initiates communications with the server and also issues one or more file system calls to a file system on the user desktop to retrieve the one or more selective files for uploading.04-12-2012
20120089901HIGH PERFORMANCE CROSS PLATFORM DOCUMENT VIEWING - A document viewing system is provided that includes a browser receiving one or more user requests to view a document being stored remotely. The browser issues a first request to a server for metadata associated with the document and based on the received metadata determines a selective number of tiles needed for viewing the document. The browser issues a second request to the server requesting the selective number of tiles for viewing the document. The selective number tiles are only those tiles available for viewing in a viewing area in the browser. The server sends the selective number of tiles in parallelized fashion to the browser. The browser receives the selective number of tiles from the server and displays the document to a user.04-12-2012

Kathryn H. Collins, Plymouth, MA US

Patent application numberDescriptionPublished
20090275496Effective quantitation of complex peptide mixtures in tissue samples and improved therapeutic methods - The instant invention provides methods for the detection and quantitation of complex peptide mixtures in tissue samples and functional readouts of the results of administration of such complex peptide mixtures. The instant invention further provides methods for administering complex peptide mixtures to a subject in need thereof, the dosage regimen and quantity determined based on the above mentioned method for detection and quantitation.11-05-2009

Mark Collins, Plymouth, MA US

Patent application numberDescriptionPublished
20120038120SYSTEM AND METHOD FOR CRYOGENIC COOLING - In accordance with an embodiment of the invention, there is provided a system for cooling a load. The system comprises a closed loop primary refrigeration system comprising: a primary compressor taking in a primary refrigerant at a low pressure and discharging the primary refrigerant at a high pressure; an insulated enclosure comprising an inlet receiving the primary refrigerant at the high pressure from the primary compressor and an outlet returning the primary refrigerant at the low pressure to the primary compressor; at least one heat exchanger within the insulated enclosure receiving the primary refrigerant at the high pressure and cooling the primary refrigerant using a secondary refrigerant from a secondary refrigeration system, the secondary refrigerant being in heat exchange relationship with the primary refrigerant in the at least one heat exchanger; an expansion unit within the insulated enclosure receiving the primary refrigerant at the high pressure from the at least one heat exchanger and discharging the primary refrigerant at the low pressure; and a supply line delivering the primary refrigerant at the low pressure to the load and a return line returning the primary refrigerant from the load to the primary refrigeration system. The system further comprises the secondary refrigeration system, wherein the secondary refrigeration system comprises at least one secondary cryogenic refrigerator. A system control unit controls operation of at least one of the primary refrigeration system and the secondary refrigeration system to provide a variable refrigeration capacity to the load based on at least one of: a pressure of the primary refrigerant delivered to the load, and at least one temperature of the load.02-16-2012

Michael C. Collins, Hingham, MA US

Scott Collins, Westford, MA US

Patent application numberDescriptionPublished
20120060520Input/Output Module and Overall Temperature Control of Samples - An automated storage and retrieval system for storing chemical and biological samples includes freezer chests maintained at an ultra-low temperature (e.g. −80° C.) or a cryogenic temperature. The freezer chests are located within a refrigerated (e.g. −20° C.) enclosure. Samples are loaded through a wall of the enclosure and are then transferred to an input/output buffer section in an ultra-low temperature or cryogenic freezer chest that is thermally segregated from a long-term storage section in the same freezer. Specialized input/output cassettes are used for transferring the samples through an input/output module into the system.03-15-2012

Tim Collins, West Newbury, MA US

Patent application numberDescriptionPublished
20090204113High Density Atrial Fibrillatrion Cycle Length (AFCL) Detection and Mapping System - Systems and methods to assist in locating the focus of an atrial fibrillation include the association of atrial fibrillation cycle length values and statistics relating thereto with temporal locations on an electrogram of a given electrode, and/or the coordination of electrode locations with respective the spectral analyses of electrogram signals and further parameters and statistics relating thereto. Ablation therapy can proceed under guidance of such information.08-13-2009

William T. Collins, Auburn, MA US

Patent application numberDescriptionPublished
20090047544Method of preparing pressureless sintered, highly dense boron carbide materials - In a method of preparing a boron carbide material, boron carbide powder is washed with essentially pure water at an elevated temperature to generate washed boron carbide powder. The washed boron carbide powder is combined with a sintering aid. The mixture of the boron carbide powder and the sintering aid is pressed to form a shaped material, and the shaped material is sintered. A sintered boron carbide material comprises a boron carbide component that includes boron carbide, elemental carbon, and not more than about 0.6 wt % of oxygen on the basis of the total weight of the boron carbide component. The sintered boron carbide material has a density of at least about 99% of the theoretical density. Another sintered boron carbide material comprises a boron carbide component that includes boron carbide, silicon carbide, elemental carbon, and not more than about 0.3 wt % oxygen on the basis of the total weight of the boron carbide component, and has a density of at least about 97% of the theoretical density.02-19-2009
20110160035METHOD OF PREPARING PRESSURELESS SINTERED, HIGHLY DENSE BORON CARBIDE MATERIALS - In a method of preparing a boron carbide material, boron carbide powder is washed with essentially pure water at an elevated temperature to generate washed boron carbide powder. The washed boron carbide powder is combined with a sintering aid. The mixture of the boron carbide powder and the sintering aid is pressed to form a shaped material, and the shaped material is sintered. A sintered boron carbide material comprises a boron carbide component that includes boron carbide, elemental carbon, and not more than about 0.6 wt % of oxygen on the basis of the total weight of the boron carbide component. The sintered boron carbide material has a density of at least about 99% of the theoretical density. Another sintered boron carbide material comprises a boron carbide component that includes boron carbide, silicon carbide, elemental carbon, and not more than about 0.3 wt % oxygen on the basis of the total weight of the boron carbide component, and has a density of at least about 97% of the theoretical density.06-30-2011

Patent applications by William T. Collins, Auburn, MA US